Evaluating the Differences in Toxicity of Novel Multilink Linker-Payload Technology

Time: 10:30 am
day: Conference Day 2


  • Comparing two ADCs with the same antibody and payload to demonstrate the importance of new linker technologies
  • Evaluating the toxicity profile of different linker-payload to improve the therapeutic index
  • Comparing two schedules of treatment in the hope of optimizing the efficacy and the toxicity profile